Sign in

DCVC Opportunity Fund II GP, LLC

CIK:0001668343
Venture Capital
$1B AUM
2 holdings
Palo Alto, CA, United States
Founded:2010
24 employees
Latest filing:Jun 30, 2025

DCVC (Data Collective) is a deep tech venture capital firm headquartered in Palo Alto, California. It was founded in 2010 and employs fewer than 25 people. The firm invests in innovative entrepreneurs and companies developing solutions to significant global challenges, particularly in sectors including artificial intelligence, climate technology, health, life sciences, and food production. DCVC supports ventures with dedicated climate and bio funds, focusing on impactful technologies and sustainable practices, and works with startups from seed to Series B stage.

Investment Strategy

DCVC invests in deep tech companies at the seed to Series B stages that leverage computational breakthroughs, biology, engineering, and advanced technologies to address high-stakes global challenges. Its investment approach emphasizes foundational science and engineering to create impactful solutions in health, sustainability, and climate. DCVC supports companies that combine scientific excellence with technological innovation, seeking outsized returns and meaningful contributions to society. Its funds, including dedicated climate and bio funds, back entrepreneurs with expertise in fields such as genetics, AI, industrial fermentation, and synthetic biology, aiming to bring breakthrough products to market and solve hard global problems.

Top Buys
R
RKLBRocket Lab Corp
+$95.3M
R
RXRXRecursion Pharmaceuticals, Inc.
-$908.8K
Top Sells
R
RKLBRocket Lab Corp
+$95.3M
R
RKLBRocket Lab USA, Inc.
-$60.6M
R
RXRXRecursion Pharmaceuticals, Inc.
-$908.8K

Top Holdings

R
RKLBRocket Lab Corp
+82.7%$95.3M
R
RXRXRecursion Pharmaceuticals, Inc.
+17.3%$20.0M

Equity Positions (2)

TickerSecurityWeightMarket ValueSharesAvg CostPriceChange (QoQ)
R
RKLB
Rocket Lab Corp82.65%$95.3M2,663,139$35.77$35.77+$95.3M
R
RXRX
Recursion Pharmaceuticals, Inc.17.35%$20.0M3,951,141$9.86$5.06-$908.8K

Industry Allocation

GUIDED MISSILES & SPACE VEHICLES & PARTS
+82.7%
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+17.3%